This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: University of Alberta. Active years: 2020-2023.
Company Filing History:
Years Active: 2020-2023
Title: Rakesh Kumar Bhat: Innovator in Cardiomyocyte Research
Introduction
Rakesh Kumar Bhat is a prominent inventor based in Edmonton, Canada. He has made significant contributions to the field of biomedical research, particularly in the development of cardiomyocytes and immunomodulatory peptides. With a total of 2 patents, his work has the potential to impact drug screening and immune response modulation.
Latest Patents
Rakesh Kumar Bhat's latest patents include two innovative inventions. The first patent focuses on recombinant cardiomyocytes and cardiomyocyte cell lines expressing the human Ether-a-go-go Related Gene (hERG) potassium ion channel. This invention provides stable cell lines that can be used for screening compounds for cardiotoxicity, including methods to determine the activity of compounds that inhibit hERG. The second patent involves immunomodulatory peptides that modulate immune responses in individuals. This patent outlines peptides that can influence cellular responses in vitro and provides compositions that are useful in methods of modulating immune responses.
Career Highlights
Rakesh Kumar Bhat is affiliated with the University of Alberta, where he conducts his research. His work has garnered attention for its innovative approach to addressing critical issues in cardiology and immunology. His contributions to the field are recognized by his peers and the scientific community.
Collaborations
Rakesh has collaborated with notable scientists, including Michael Houghton and Adrian Egli. These collaborations have further enhanced the impact of his research and have contributed to advancements in the field.
Conclusion
Rakesh Kumar Bhat is a distinguished inventor whose work in cardiomyocyte research and immunomodulatory peptides holds promise for future medical advancements. His patents reflect a commitment to innovation and a desire to improve health outcomes.